Patents by Inventor Jason Kenneth Dutra

Jason Kenneth Dutra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240238425
    Abstract: Described herein are 3-fluoro-4-hydroxybenzamide-containing inhibitors and/or degraders, and pharmaceutical compositions containing 3-fluoro-hydroxybenzamide-containing inhibitors and/or degraders. In some embodiments, the 3-fluoro-4-hydroxybenzamide-containing compounds of the disclosure can be used to treat a condition, for example, nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Type: Application
    Filed: December 15, 2023
    Publication date: July 18, 2024
    Applicant: Pfizer Inc.
    Inventors: Jan Antoinette Cusi Romero Adams, Yotam Ashkenazi, Matthew Frank Brown, Jason Kenneth Dutra, Michelle Renee Garnsey, Xinjun Hou, Jisun Lee, Yajing Lian, Deane Milford Nason, II, Steven Victor O'Neil, Amanda Brooke Pecora, Alistair Dean Richardson, Matthew Forrest Sammons, Yang Wang, Ann Sorrentino Wright, Jun Xiao, Lei Zhang, Liying Zhang
  • Publication number: 20240150334
    Abstract: Described herein are compounds of Formula I, wherein the variables are defined herein, their use as HSD17B13 inhibitors and/or degraders, pharmaceutical compositions containing such compounds and their use to treat, for example, NAFLD and NASH.
    Type: Application
    Filed: October 6, 2023
    Publication date: May 9, 2024
    Applicant: Pfizer Inc.
    Inventors: Jan Antoinette Cusi Romero Adams, Bruce Michael Bechle, Jason Kenneth Dutra, Michelle Renee Garnsey, Xinjun Hou, Jisun Lee, Deane Milford Nason, II, Steven Victor O'Neil, Danica Antonia Rankic, Yang Wang, Ann Sorrentino Wright, Lei Zhang, Liying Zhang, David James Edmonds
  • Patent number: 6878726
    Abstract: The present invention relates to compounds of the formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, A, X and Y are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: April 12, 2005
    Assignee: Pfizer Inc.
    Inventors: Hengmaio Cheng, Subas Man Sakya, Jason Kenneth Dutra
  • Publication number: 20040259879
    Abstract: The present invention relates to compounds of the formula 1
    Type: Application
    Filed: July 16, 2004
    Publication date: December 23, 2004
    Inventors: Hengmaio Cheng, Subas Man Sakya, Jason Kenneth Dutra
  • Publication number: 20020058681
    Abstract: The present invention relates to compounds of the formula 1
    Type: Application
    Filed: March 2, 2001
    Publication date: May 16, 2002
    Inventors: Hengmiao Cheng, Subas Man Sakya, Jason Kenneth Dutra